14-3-3 Cerebrospinal fluid protein and Creutzfeldt-Jakob disease [4] (multiple letters)

Annals of Neurology

Volumn 47, Issue 5, 2000, Pages 683-684

  Zeidler, Martin ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; LETTER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION;

CEREBROSPINAL FLUID PROTEINS; CREUTZFELDT-JAKOB SYNDROME; HUMANS;

EID: 0034017712     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200005)47:5<683::AID-ANA25>3.0.CO;2-V     Document Type: Letter

References (4)

1. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40
2. Brandel JP, Beaudry P, Delasnerie-Laupretre N, Laplanche JL. Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid. Rev Neurol 1999;155:148-151
3. Saiz A, Graus F, Dalmau J, et al. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999;46:774-777
4. Report of the WHO consultation on the global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. WHO/EMC/ZDI/98.9. Geneva: World Health Organization, 1998